Tryton I, First-In-Man (FIM) study: six month clinical and angiographic outcome, analysis with new quantitative coronary angiography dedicated for bifurcation lesions.

@article{Onuma2008TrytonIF,
  title={Tryton I, First-In-Man (FIM) study: six month clinical and angiographic outcome, analysis with new quantitative coronary angiography dedicated for bifurcation lesions.},
  author={Yoshinobu Onuma and R. -D. M{\"u}ller and Steve Ramcharitar and Robert Jan M van Geuns and Yves Louvard and Marie-ang{\'e}le Morel and Marie-claude Morice and Richard 1. Davis and Aaron V. Kaplan and Thierry Lefevre and Eberhard Grube and Patrick Washington Serruys},
  journal={EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology},
  year={2008},
  volume={3 5},
  pages={546-52}
}
AIM To report clinical and angiographic follow-up at 6 months after implantation of the Tryton Side-Branch Stent dedicated to bifurcation, in conjunction with standard workhorse drug-eluting stent (DES). METHODS AND RESULTS Patients having angina or silent myocardial ischaemia with de novo bifurcation lesions were enrolled at three sites. The Tryton stent was first placed in the side-branch and a standard DES subsequently implanted in the main-branch. The primary endpoint was freedom from in… CONTINUE READING
24 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

Similar Papers

Loading similar papers…